Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

The document lists research on Pemetrexed and Cisplatin for lung cancer but doesn't give a final conclusion.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Pemetrexed with cisplatin is safer and more effective than gemcitabine with cisplatin for advanced lung cancer.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

DFMO may help control hair growth and treat cancer.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

The document concludes that hair loss has many causes and treatments vary, including medication for pattern baldness and addressing underlying issues for other types.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Horticultural therapy helped cancer patients feel hopeful and positive about their disease experience.

Cancer survivors need better skin care to improve their quality of life.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.